查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1585766

骨形成蛋白市場：依類型、應用分類 - 2025-2030 年全球預測

Bone Morphogenetic Protein Market by Type (rhBMP-2, rhBMP-7), Application (Oral Maxillofacial, Reconstruction, Spinal fusion) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年骨形成蛋白市值為16.3億美元，預計2024年將達到18.8億美元，複合年成長率為14.81%，預計到2030年將達到43.1億美元。

骨形成蛋白(BMP) 是一組已知在骨骼和軟骨形成中發揮重要作用的生長因子。對 BMP 的需求在於其在整形外科手術、脊椎融合手術和牙科治療中的應用，以促進骨骼生長和癒合。對 BMP 的需求延伸到醫療和牙科領域，凸顯了它們從骨骼修復到組織工程的廣泛應用。市場洞察預測，骨骼相關疾病增加、人口老化和再生醫學進步將推動積極成長。此外，重組DNA技術等技術創新正在擴大BMP的治療應用。

主要市場統計
基準年[2023] 16.3億美元
預測年份 [2024] 18.8億美元
預測年份 [2030] 43.1億美元
複合年成長率（%） 14.81%

主要的成長要素包括生物技術的進步和醫療保健支出的增加以及全球移植骨替代物市場的擴大。然而，潛在的挑戰包括高昂的治療成本、嚴格的法律規範以及副作用的風險，例如不必要的骨骼生長。在快速成長的經濟體中，未滿足的需求創造了商機，這些經濟體的整形外科和牙科手術呈上升趨勢。公司可以透過利用與研究機構的策略夥伴關係關係來增加產品平臺和市場佔有率。此外，推出具有成本效益的 BMP 為基礎的產品可能會開拓新的市場。

創新和研究可以專注於開發副作用較少的 BMP 配方，並改善輸送系統以提高功效和安全性。個人化醫療，即根據患者個別情況客製化 BMP 的使用，以達到最佳效果，這也是一個創新的成熟領域。儘管市場競爭激烈，但它是一個充滿活力的市場，透過解決限制和利用新技術，具有成長潛力。投資於強大的研發、策略性地域擴張和技術整合的公司最有可能充分利用市場潛力。長期成功取決於平衡技術創新與監管條件和承受能力，以在充滿挑戰的醫療保健環境中維持成長。

市場動態：揭示快速發展的骨形成蛋白市場的關鍵市場洞察

供需的動態交互作用正在改變骨形成蛋白市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 運動相關傷害和脊椎融合手術的發生率上升
    • 人們對骨形成蛋白的認知不斷增強
    • 骨生成激素在口腔顎顏面骨缺損臨床治療的應用
  • 市場限制因素
    • 治療費用高
  • 市場機會
    • 對微創醫療程序的需求不斷成長
    • 外傷治療方法的進展
  • 市場挑戰
    • 替代療法和產品的可用性，例如骨移植物和支架；

波特五力：駕馭骨形成蛋白市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外在對骨形成蛋白市場的影響

外部宏觀環境因素在塑造骨形成蛋白市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解骨形成蛋白市場的競爭格局

對骨形成蛋白市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位骨形成蛋白市場供應商績效評估

FPNV定位矩陣是評估骨形成蛋白市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了骨形成蛋白市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對骨形成蛋白市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監管核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 運動相關傷害和脊椎融合手術的發生率上升
      • 提高對骨形成蛋白的認知
      • 骨形成蛋白在臨床口腔顎顏面骨缺損治療的應用
    • 抑制因素
      • 手續成本高
    • 機會
      • 對微創醫療程序的需求增加
      • 創傷治療線的進展
    • 任務
      • 替代療法和產品的可用性，例如骨移植物和支架；
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章骨形成蛋白市場：依類型

  • 重組HBMP-2基因
  • 重組HBMP-7基因

第7章骨形成蛋白市場：依應用分類

  • 口腔顎顏面
  • 重建
  • 脊椎融合手術
  • 創傷

第8章美洲骨形成蛋白市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太骨形成蛋白市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲/中東/非洲骨形成蛋白市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Akron Biotechnology, LLC
  • AlloSource, Inc.
  • Bioventus LLC
  • Cellumed Co. Ltd
  • Ember Therapeutics Inc.
  • Hangzhou Jiuyuan Gene Engineering Co .,Ltd
  • HiMedia Laboratories
  • Integra Lifesciences Corporation
  • Johnson & Johnson Services Inc.
  • Medtronic PLC
  • Merck KGaA
  • Olympus Corporation
  • Orthofix Holdings, Inc.
  • Pfizer, Inc.
  • Prospec-Tany Technogene Ltd.
  • R&D Systems, Inc.
  • ScienCell Research Laboratories, Inc.
  • Sino Biological Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Thermo Fisher Scientific, Inc
  • Xtant Medical Holdings, Inc
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-ED54C46E81E8

The Bone Morphogenetic Protein Market was valued at USD 1.63 billion in 2023, expected to reach USD 1.88 billion in 2024, and is projected to grow at a CAGR of 14.81%, to USD 4.31 billion by 2030.

Bone Morphogenetic Proteins (BMPs) are a group of growth factors known for their critical role in the formation of bone and cartilage. The necessity of BMPs lies in their application in orthopedic surgeries, spinal fusions, and dental procedures to promote bone growth and healing. The demand for BMPs extends across medical and dental fields, emphasizing their application scope ranging from bone repair to tissue engineering. Market insight indicates a positive growth trajectory fueled by increasing incidences of bone-related disorders, an aging population, and advancements in regenerative medicine. Further, technological innovations, including recombinant DNA technology, have expanded BMPs' therapeutic use.

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.88 billion
Forecast Year [2030] USD 4.31 billion
CAGR (%) 14.81%

Key growth influencers are advances in biotechnology and increasing healthcare expenditure alongside an expanding global market for bone graft substitutes. However, potential challenges include high treatment costs, strict regulatory frameworks, and the risk of adverse side effects, such as unwanted bone growth. Opportunities emerge from unmet needs in rapidly growing economies with increasing orthopedic and dental procedure rates. Companies could capitalize on strategic partnerships with research institutions to enhance product pipelines and market presence. Moreover, the introduction of cost-effective BMP-based products could open up new markets.

Innovation and research can focus on creating BMP variants with lower side-effect profiles and enhancing delivery systems to improve efficacy and safety. Another area ripe for innovation is personalized medicine, aligning BMP use with individual patient profiles for optimized results. The market, while competitive, remains dynamic, with potential for growth through addressing constraints and leveraging emerging technologies. Companies investing in robust R&D, strategic geographic expansions, and technology integration are best positioned to harness market potentials. Long-term success will depend on balancing innovation with regulatory compliance and affordability to sustain growth in a challenging healthcare landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Morphogenetic Protein Market

The Bone Morphogenetic Protein Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence rate of sports-related injuries and spinal fusion procedure
    • Increasing awareness regarding the bone morphogenetic protein
    • Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
  • Market Restraints
    • High cost of the procedure
  • Market Opportunities
    • Growing demand for minimally invasive medical procedures
    • Developing advancements in treatment lines for traumatic injuries
  • Market Challenges
    • Availability of the substitute treatment and products such as bone grafts and scaffolds

Porter's Five Forces: A Strategic Tool for Navigating the Bone Morphogenetic Protein Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Morphogenetic Protein Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Morphogenetic Protein Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Morphogenetic Protein Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Morphogenetic Protein Market

A detailed market share analysis in the Bone Morphogenetic Protein Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Morphogenetic Protein Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Morphogenetic Protein Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Morphogenetic Protein Market

A strategic analysis of the Bone Morphogenetic Protein Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Morphogenetic Protein Market, highlighting leading vendors and their innovative profiles. These include Akron Biotechnology, LLC, AlloSource, Inc., Bioventus LLC, Cellumed Co. Ltd, Ember Therapeutics Inc., Hangzhou Jiuyuan Gene Engineering Co .,Ltd, HiMedia Laboratories, Integra Lifesciences Corporation, Johnson & Johnson Services Inc., Medtronic PLC, Merck KGaA, Olympus Corporation, Orthofix Holdings, Inc., Pfizer, Inc., Prospec-Tany Technogene Ltd., R&D Systems, Inc., ScienCell Research Laboratories, Inc., Sino Biological Inc., Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific, Inc, Xtant Medical Holdings, Inc, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Morphogenetic Protein Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across rhBMP-2 and rhBMP-7.
  • Based on Application, market is studied across Oral Maxillofacial, Reconstruction, Spinal fusion, and Trauma.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence rate of sports-related injuries and spinal fusion procedure
      • 5.1.1.2. Increasing awareness regarding the bone morphogenetic protein
      • 5.1.1.3. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing demand for minimally invasive medical procedures
      • 5.1.3.2. Developing advancements in treatment lines for traumatic injuries
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of the substitute treatment and products such as bone grafts and scaffolds
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bone Morphogenetic Protein Market, by Type

  • 6.1. Introduction
  • 6.2. rhBMP-2
  • 6.3. rhBMP-7

7. Bone Morphogenetic Protein Market, by Application

  • 7.1. Introduction
  • 7.2. Oral Maxillofacial
  • 7.3. Reconstruction
  • 7.4. Spinal fusion
  • 7.5. Trauma

8. Americas Bone Morphogenetic Protein Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bone Morphogenetic Protein Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bone Morphogenetic Protein Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Akron Biotechnology, LLC
  • 2. AlloSource, Inc.
  • 3. Bioventus LLC
  • 4. Cellumed Co. Ltd
  • 5. Ember Therapeutics Inc.
  • 6. Hangzhou Jiuyuan Gene Engineering Co .,Ltd
  • 7. HiMedia Laboratories
  • 8. Integra Lifesciences Corporation
  • 9. Johnson & Johnson Services Inc.
  • 10. Medtronic PLC
  • 11. Merck KGaA
  • 12. Olympus Corporation
  • 13. Orthofix Holdings, Inc.
  • 14. Pfizer, Inc.
  • 15. Prospec-Tany Technogene Ltd.
  • 16. R&D Systems, Inc.
  • 17. ScienCell Research Laboratories, Inc.
  • 18. Sino Biological Inc.
  • 19. Smith & Nephew PLC
  • 20. Stryker Corporation
  • 21. Thermo Fisher Scientific, Inc
  • 22. Xtant Medical Holdings, Inc
  • 23. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. BONE MORPHOGENETIC PROTEIN MARKET RESEARCH PROCESS
  • FIGURE 2. BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BONE MORPHOGENETIC PROTEIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BONE MORPHOGENETIC PROTEIN MARKET DYNAMICS
  • TABLE 7. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RHBMP-7, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY ORAL MAXILLOFACIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY RECONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY SPINAL FUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TRAUMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BONE MORPHOGENETIC PROTEIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. BONE MORPHOGENETIC PROTEIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. BONE MORPHOGENETIC PROTEIN MARKET, FPNV POSITIONING MATRIX, 2023